A Single-Center, Open-Label, Single-Dose Study To Assess The Pharmacokinetics, Safety, And Tolerability Of Moxidectin In Subjects Aged 4 To 11 Years ( '=12 kg) With Or Without Onchocerca Volvulus Infection
Latest Information Update: 26 May 2014
At a glance
- Drugs Moxidectin (Primary)
- Indications Onchocerciasis
- Focus Pharmacokinetics
- Sponsors Pfizer
- 26 May 2014 New trial record